Stay updated on SubQ Efgartigimod in CIDP Clinical Trial

Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page now displays revision tag v3.6.3, replacing v3.6.0, indicating a small update to the page's documentation/versioning rather than changes to study details or visible content.
    Difference
    0.0%
    Check dated 2026-07-01T10:22:32.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A new publication entry has been added to the Publications section, listing authors and bibliographic details for a CIDP-related genetic study.
    Difference
    0.0%
    Check dated 2026-06-24T05:51:40.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now indicates that enrollment is closed, and new guidance sections related to reading the study record and joining the study have been added. A formatting change to the Intervention/Treatment label and a revision note were also applied.
    Difference
    0.1%
    Check dated 2026-06-09T21:56:03.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3. This indicates a minor internal update to the trial entry rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-05-19T12:30:33.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Taiwan enrollment location updated: Taoyuan District, Taiwan was removed and Taoyuan, Taiwan was added to the study's locations.
    Difference
    0.0%
    Check dated 2026-05-05T05:39:19.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    A new Revision: v3.5.3 was added, replacing the previous Revision: v3.5.2. This indicates a small metadata update to the page, not affecting study content.
    Difference
    0.0%
    Check dated 2026-04-27T20:11:18.000Z thumbnail image

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.